Copper oxide nanoparticles suppress retinal angiogenesis via inducing endothelial cell cuproptosis

Haorui Zhang,Chang Cai,Qing Li,Zheng Nie,Mengzhu Wang,Yongxuan Liu,Wei Shen,Hongyuan Song
DOI: https://doi.org/10.2217/nnm-2023-0301
2024-02-02
Nanomedicine
Abstract:Background: Copper oxide nanoparticles (CuO NPs) exhibit antitumor activity; however, their potential as an antiangiogenesis agent is unknown. Materials & methods: The antiangiogenesis properties of CuO NPs were evaluated in vitro and in vivo and the underlying mechanism was examined using RNA sequencing and metabolomic analyses. Results: CuO NPs inhibited endothelial cell function in vitro . They also mitigated retinal vasculature development and alleviated pathological retinal angiogenesis in vivo . RNA sequencing and metabolomic analyses revealed that CuO NPs disrupt the tricarboxylic acid cycle and induce cuproptosis, which was further supported by evaluating cuproptosis-related metabolites and proteins. Conclusion: CuO NPs may be an effective antiangiogenic agent for the treatment of retinal angiogenesis. We demonstrated that CuO nanoparticles (NPs) exhibit significant antiangiogenic properties in vitro and in vivo . The combined analysis of metabolomics and RNA sequencing revealed that CuO NPs disrupt the TCA cycle pathway, ultimately leading to cuproptosis.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?